NET PROFIT (x1000 NOK)
EMPLOYEES
Biomediq A/S
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
-87
|
-34
|
424 |
Total assets |
179
|
320
|
1,457 |
Current assets |
179
|
320
|
1,457 |
Current liabilities |
71
|
75
|
123 |
Equity capital |
81
|
160
|
1,251 |
- share capital |
603
|
566
|
536 |
Employees (average) |
7
![]() |
7
![]() |
7 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
45.3%
|
50.0%
|
85.9% |
Turnover per employee |
0
![]() |
0
![]() |
0 |
Profit as a percentage of turnover | |||
Return on assets (ROA) | |||
Current ratio |
252.1%
|
426.7%
|
1184.6% |
Return on equity (ROE) |
-107.4%
|
-21.2%
|
33.9% |
Change turnover |
0
![]() |
0
![]() |
0 |
Change turnover % | |||
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.